Hepatocellular carcinoma (HCC) is a chronic liver disease that is highly fatal if not detected
and treated early. The incidence and death rate of HCC have been increasing in recent …

A couple of molecular-targeting medications, such as Lenvatinib, are available for the
treatment of hepatocellular carcinoma (HCC) in addition to Sorafenib in an advanced stage …

Background and aims Liver transplantation (LT) is the primary curative option for cirrhotic
patients with early-stage hepatocellular carcinoma (HCC). However, tumor recurrence …

Hepatocellular carcinoma (HCC) is one of most common cancers that cause death in the
world. Thermal ablation (TA) is an important alternative treatment method for HCC patients …

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality
worldwide. Much recent research has delved into understanding the underlying molecular …

Background The combination therapy of trans-arterial chemoembolization (TACE) and
sorafenib were proved to be one of the effective methods for intermediate and advanced …

Natural killer (NK) cells and type 1 innate lymphoid cells (ILC1) are specific innate lymphoid
cell subsets that are key for the detection and elimination of pathogens and cancer cells. In …

Hepatocellular carcinoma (HCC) is the most common type of primary liver malignancy and
the fourth leading cause of cancer-related deaths globally. HCC is often diagnosed in late …

CD38 is expressed on the surface of many immune cells, which are closely associated with
antitumor immunity and immune tolerance of tumor cells. Therefore, monitoring CD38 …

RNA-binding proteins (RBPs) play a crucial role in the biological processes of liver
hepatocellular carcinoma (LIHC). Peptidyl-prolyl cis-trans isomerase H (PPIH), an RBP …